Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios

Thyroid cancer is the most frequent endocrine tumor. In locally advanced or metastatic disease there are only two types of treatment available: radioactive iodine (RAI) while the disease is RAI‐sensitive and multikinase inhibitors, lenvatinib and sorafenib, when the disease becomes RAI‐refractory. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafón, Carles, Castelo, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537053/
https://www.ncbi.nlm.nih.gov/pubmed/36202604
http://dx.doi.org/10.1002/cam4.5154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537053/
https://www.ncbi.nlm.nih.gov/pubmed/36202604
http://dx.doi.org/10.1002/cam4.5154

Ejemplares similares